Vabysmo™ (faricimab-svoa)
for Macular Degeneration

Vabysmo (faricimab-svoa) is an eye injection used to treat wet age-related macular degeneration (nAMD), diabetic macular edema (DME), and macular edema from retinal vein occlusion (RVO) in adults. It blocks two proteins, VEGF and Ang-2, which cause abnormal blood vessel growth and fluid leakage in the eye. By reducing swelling and leakage, Vabysmo helps maintain and improve vision. It is a bispecific antibody given by intravitreal injection.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Macular Degeneration